Literature DB >> 25556047

Severe macrolide-resistant Mycoplasma pneumoniae pneumonia associated with macrolide failure.

Kai-Ning Cheong1, Susan S Chiu1, Betsy Wai-Ka Chan2, Kelvin Kai-Wang To2, Eunice Lai-Yin Chan1, Pak-Leung Ho3.   

Abstract

We investigated differences in outcomes between 68 children hospitalized with macrolide-sensitive Mycoplasma pneumoniae pneumonia (MSMP group) and 25 children hospitalized with macrolide-resistant M. pneumoniae pneumonia (MRMP group). In the MRMP group, 19 children received macrolides and clinical failure occurred in six of which five had pneumonia progression during therapy.
Copyright © 2014. Published by Elsevier B.V.

Entities:  

Keywords:  atypical pneumonia; empyema; macrolides

Mesh：

Substances：

Year:  2014        PMID： 25556047     DOI： 10.1016/j.jmii.2014.11.003

Source DB:  PubMed          Journal:  J Microbiol Immunol Infect        ISSN： 1684-1182            Impact factor:   4.399


  12 in total

Review 1.  Mycoplasma pneumoniae from the Respiratory Tract and Beyond.

Authors:  Ken B Waites; Li Xiao; Yang Liu; Mitchell F Balish; T Prescott Atkinson
Journal:  Clin Microbiol Rev       Date:  2017-07       Impact factor: 26.132

2.  Emergence of Macrolide-Resistant Mycoplasma pneumoniae in Hong Kong Is Linked to Increasing Macrolide Resistance in Multilocus Variable-Number Tandem-Repeat Analysis Type 4-5-7-2.

Authors:  Pak-Leung Ho; Pierra Y Law; Betsy W K Chan; Chun-Wai Wong; Kelvin K W To; Susan S Chiu; Vincent C C Cheng; Wing-Cheong Yam
Journal:  J Clin Microbiol       Date:  2015-09-02       Impact factor: 5.948

Review 3.  Mechanism of resistance acquisition and treatment of macrolide-resistant Mycoplasma pneumoniae pneumonia in children.

Authors:  Hyeon-Jong Yang; Dae Jin Song; Jung Yeon Shim
Journal:  Korean J Pediatr       Date:  2017-06-22

4.  Macrolide Resistance and Its Impacts on M. Pneumoniae Pneumonia in Children: Comparison of Two Recent Epidemics in Korea.

Authors:  Jong Hyun Kim; Jee Yong Kim; Chang Hoon Yoo; Won Hee Seo; Young Yoo; Dae Jin Song; Ji Tae Choung
Journal:  Allergy Asthma Immunol Res       Date:  2017-07       Impact factor: 5.764

5.  Clinical features and seasonal variations in the prevalence of macrolide-resistant Mycoplasma pneumoniae.

Authors:  Yusaku Akashi; Daisuke Hayashi; Hiromichi Suzuki; Masanari Shiigai; Koji Kanemoto; Shigeyuki Notake; Takumi Ishiodori; Hiroichi Ishikawa; Hironori Imai
Journal:  J Gen Fam Med       Date:  2018-08-23

6.  Increased procalcitonin level is a risk factor for prolonged fever in children with Mycoplasma pneumonia.

Authors:  Ji Eun Jeong; Ji Eun Soh; Ji Hee Kwak; Hye Lim Jung; Jae Won Shim; Deok Soo Kim; Moon Soo Park; Jung Yeon Shim
Journal:  Korean J Pediatr       Date:  2018-08-15

7.  Low Bacterial Co-infection Invalidates the Early Use of Non-anti-Mycoplasma pneumoniae Antibiotics in Pediatric Refractory Mycoplasma pneumoniae Pneumonia Patients.

Authors:  Jin-Rong Liu; Jie Lu; Fang Dong; Hui-Min Li; Hui Liu; Xiao-Lei Tang; Yong-Li Guo; Shun-Ying Zhao
Journal:  Front Pediatr       Date:  2018-10-26       Impact factor: 3.418

8.  Macrolide-Resistant Mycoplasma pneumoniae Infections in Pediatric Community-Acquired Pneumonia.

Authors:  Yu-Chin Chen; Wei-Yun Hsu; Tu-Hsuan Chang
Journal:  Emerg Infect Dis       Date:  2020-07       Impact factor: 6.883

9.  The clinical significance of IL-6 s and IL-27 s in Bronchoalveolar lavage fluids from children with mycoplasma pneumoniae pneumonia.

Authors:  Jie Zhao; Yuyun Li; Wen Zhang
Journal:  BMC Infect Dis       Date:  2020-05-11       Impact factor: 3.090

10.  Ameliorative Effects of Infantile Feire Kechuan Oral Solution on Mycoplasma Pneumoniae Pneumonia in Infant Mouse and Rat Models.

Authors:  Shanshan Guo; Lei Bao; Tiange Qu; Xin Mao; Yingjie Gao; Yingli Xu; Xiaolan Cui
Journal:  Evid Based Complement Alternat Med       Date:  2018-09-17       Impact factor: 2.629
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.